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Abstract 
Objectives: To describe factors associated with prevalent and incident foot pain in a 
population-based cohort of older adults (n=1092). 
Study Design: Longitudinal observational study. 
Main Outcome Measures: Prevalent foot pain, incident foot pain after 5 years.   
Methods: Potential correlates included demographic factors, anthropometry, leg 
strength, metabolic factors, steps per day (using pedometer), pain at 6 other sites, 
and psychological wellbeing.  Data were analysed using log binomial models. 
Results:  Participants were aged 50-80 years (mean 63 years), 49% male, mean 
BMI 27.8±4.7 at baseline.  Baseline prevalence of foot pain at baseline was 38% and 
incidence of new pain after 5 years was 20%.  Body mass index (BMI), pain at other 
sites (neck, hands, knees, pain at ≥3 sites), and poorer psychological wellbeing were 
independently associated with baseline foot pain.  Baseline BMI and pain in the 
neck, hands, and knees were independently associated with incident foot pain; but 
change in weight or BMI, total number of painful joints and psychological wellbeing 
were not.  Self-reported diabetes and cigarette smoking were not associated with 
prevalent or incident foot pain.   
Conclusions: This study demonstrates that heavier body mass and joint pain at 
multiple sites were consistently associated with prevalent foot pain and predict 
incident foot pain.  Addressing excess body mass and taking a global approach to 
the treatment of pain may reduce prevalence and incidence of foot pain in older 
adults.  
 
 
Key words:  Foot; Obesity; Pain; Aged; Body Composition; Cohort Studies; 
Pain/epidemiology/  
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Introduction 
Foot pain is common, with an estimated 24% of adults reporting foot pain on most 
days [1]. Foot pain is important, because it is an independent risk factor for 
locomotor disability [2], impaired balance, and increased risk of falling [3, 4], and 
functional activities of daily living [5, 6] among community–dwelling older adults.  It 
also increases risk of developing knee symptoms and symptomatic radiographic 
knee OA in people with knee OA or at high risk of developing knee OA [7]. 
Therefore, identifying factors associated with existing and new foot pain is required 
in order to reduce pain in individuals and to address the burden of foot pain in the 
community . 
Individuals with higher BMI are more likely to have foot pain [8], more likely to have 
existing foot pain persist, and to develop new foot problems [9, 10].  Effect sizes are 
in the small to medium range, both cross-sectionally [8] and longitudinally [9, 10].  
The component of body mass most strongly associated with foot pain is fat mass, 
with evidence from both cross–sectional [11, 12] and longitudinal [12, 13] studies, 
and particularly fat in the android distribution (adipose tissue that accumulates in the 
abdominal region). This suggests that the mechanism for obesity-related foot pain 
may be metabolic as well as mechanical. 
Depressive symptoms are associated with presence [9, 14] and severity [15-17] of 
foot pain cross–sectionally.  The association also holds in the reverse, with people 
with existing foot pain also having lower scores on health-related quality of life 
questionnaires cross–sectionally [18, 19].  Poor mental health predicts worsening of 
foot pain longitudinally in community dwelling participants over 3 years [20].  
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Cross-sectionally, foot pain is associated with pain in multiple sites elsewhere:  back, 
hips, knees [17, 18], hands and / or wrists [17].  Multi-site joint pain is important 
because having pain in some sites predicts incidence of new pain elsewhere  [21], 
and because number of sites of pain is an effect modifier  [22], leading to poorer 
quality of life both cross-sectionally [23] and longitudinally [23, 24], equivalent to a 
dose response for pain.  No studies have examined the effect of multi-site joint pain 
on pain in new joints, whether some joints are more closely associated with foot pain 
than others, if the effects are additive, and whether these associations continue to 
hold longitudinally as well as cross-sectionally.  We have previously reported that 
multi-site joint pain is also associated with fat mass and body mass [25]; however, it 
is unclear whether these factors are independent in the context of foot pain. 
This study aimed to describe non–structural factors associated with foot pain both 
cross–sectionally and longitudinally over 5 years, in a community dwelling sample of 
older adults. 
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Methods 
Study design, setting and participants 
The Tasmanian Older Adult Cohort (TASOAC) study is a population–based cohort 
study, which aims to identify factors associated with the development and 
progression of osteoarthritis and osteoporosis in older adults.  Men and women aged 
50-80 years in 2002 were selected from the electoral roll in Southern Tasmania 
(population 229,000) using sex-stratified random sampling (response rate 57%).  
Participants were excluded if they lived in an aged care facility, or had 
contraindications to magnetic resonance imaging.  The Southern Tasmanian Health 
and Medical Human Research Ethics Committee approved the study, and we 
obtained written informed consent from all participants.   
Baseline data (Phase 1) were collected from February 2002 to September 2004 in 
1099 participants.  Participants who did not have an MRI at Phase 1 (n= 105) were 
excluded from further participation in the study, as the primary aim of TASOAC was 
to measure progression of knee osteoarthritis.  Follow up data (Phase 2 and 3) were 
collected on average 2.6 years (range 1.4 – 4.8) and 5 years (range 3.6 – 6.9 years) 
later, in 875 and 768 participants, respectively.  Data in this paper were limited to 
participants with questionnaire data at Phase 1 (cross-sectional analyses) and 
Phase 3 (longitudinal analyses). 
Outcome:  Foot pain  
Self-reported foot pain was assessed by questionnaire at Phases 1–3.  Participants 
were asked “Do you have pain at any of these sites?”.  New foot pain was calculated 
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as presence of pain at Phase 3 in study participants who did not report foot pain at 
Phase 1. 
Predictors and correlates 
Measures assessed by questionnaire 
Participants were asked whether they had pain at 7 sites (neck, back, hands, 
shoulders, hips, knees, or feet; all yes / no options).  The Assessment of Quality of 
Life (AQoL) questionnaire [26] was administered.  It is a generic quality of life (QoL) 
instrument which is a valid measure of QoL [27] and is reliable in population-based 
settings (Cronbach’s α = 0.81) [28].  We used the psychological wellbeing subscale, 
which has three items (“If I think about how I sleep”, “thinking about how I generally 
feel (regarding anxiety and depression)”, “How much pain or discomfort do I 
experience?”) with four response levels (scored 0-3 for each item), with scores for 
this subscale ranging from 0-9.  We also collected self-reported current cigarette 
smoking prevalence and diabetes status (yes / no). 
Anthropometry 
We calculated BMI [weight (in kilograms)/height (in meters)2] using weight measured 
to the nearest 0.1 kg (with shoes, socks, bulky clothing and headwear removed) 
using a single pair of calibrated electronic scales (Seca Delta Model 707), and height 
measured to the nearest 0.1 cm (with shoes and socks removed) using a 
stadiometer.  Waist and hip circumferences were measured to the nearest 0.1 cm 
using a constant tension tape (Figure Finder tape measure) directly over the skin. 
The arithmetic mean of two measurements was used for analysis. Participants 
underwent a whole-body dual X-ray absorptiometry (DXA) scan using a Hologic 
AUTHOR ACCEPTED MANUSCRIPT 
Page 7 
© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 
license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
https://doi.org/10.1016/j.maturitas.2018.10.004 
Delphi densitometer (Hologic, Waltham, MI), from which body composition was 
determined.  We excluded participants from the DXA scans if their weight exceeded 
130 kg (n=3).   The analysis provided mass in grams of total body fat and trunk fat.  
Serum lipids  
Study participants provided a blood sample, after a 12-hour overnight fast.  This was 
used to assess total cholesterol, high-density lipoprotein (HDL) cholesterol, and 
triglycerides.  These were assessed enzymatically using an Olympus AU5400 
automated analyzer. The concentration of LDL cholesterol was calculated by using 
the Friedewald formula [29]. Assays were performed on thawed blood samples.  
Other measures 
Blood pressure was measured using an OMRON HEM907 digital automatic blood 
pressure monitor; the arithmetic mean of two measurements was used for analysis 
(less than 2 mmHg apart). Presence of metabolic syndrome was calculated using the 
Alberti et al [30] criteria.  Metabolic syndrome was defined as 3 or more of 5 risk 
factors: abdominal obesity (waist circumference (WC) using European criteria >102 
cm in men; >88 cm in women), hypertriglyceridemia (triglycerides (TG) ≥1.7 mmol/L), 
low level of high-density lipoprotein cholesterol (HDL-C) (i.e. HDL-C 1.0 mmol/L in 
men and 1.3 mmol/L in women), high blood pressure (BP) (BP ≥130/85 mmHg) and 
high levels of fasting plasma glucose (GL) (i.e. GL ≥110 mg/dL (≥5.5 mmol/L)  [30]. 
Leg strength was measured to the nearest kilogram in both legs simultaneously, 
using a dynamometer (TTM Muscular Meter, Tokyo, Japan) as previously 
described [31].  Physical activity (number of steps per day) was measured using a 
pedometer (Omron HJ-003 & HJ-102, Omron Healthcare, Kyoto, Japan). Briefly, 
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number of steps per day was calculated as an average of seven consecutive days 
and averaged across two time points in different seasons [32].   
Statistical analysis 
Basic group comparisons were performed using Students' t-tests and chi square 
tests to examine differences in means and proportions, respectively.  The two 
outcomes; baseline (prevalent) foot pain, and incident foot pain after five years, were 
modelled using log binomial regression [33]. All potential predictors were assessed 
adjusted for age and sex. Number of sites of pain were categorised for entry into the 
models.   
We selected BMI for entry into the models in Table 2 and Table 4 as the units are 
standardised for both genders, however, associations with other anthropometry 
measures and foot pain were investigated further (Table 3).  We applied inverse 
probability weighting (IPW) to adjust for potential bias due to non-random dropout of 
study participants in the longitudinal model.  The IPW model was based on age, sex, 
smoking status, diagnosed diabetes, prevalence of neck pain and steps per day at 
baseline. 
Statistical significance was defined as a p value ≤0.05 (two tailed). We used Stata 
15.0 (StataCorp LP) for all statistical analyses.  
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Results 
Participants who reported foot pain at baseline (in 2002-2004, n=1092) were more 
likely to be female, have more obese anthropometry profiles (weight, BMI, waist 
circumference, waist-to-hip ratio), have diagnosed diabetes or metabolic syndrome, 
and have weaker leg strength.  They walked fewer steps per day, reported pain in 
greater numbers of sites and reported worse quality of life (psychological wellbeing 
subscale).  Participants with incident foot pain at 5 years  (2007-2009, n=476) were 
more likely to be female, have higher BMI and hip circumference, less leg strength, 
have pain at greater number of sites and have poorer psychological wellbeing (Table 
1).   
Approximately 30% of study participants were lost to follow up over 5 years of 
observation, with those lost to follow up older (65 vs 62 years), more likely to smoke 
cigarettes (18 vs 10%), have been diagnosed with diabetes (9.2 vs 3.2%), walk 
fewer steps per day (8100 vs 9100), and have neck pain (41 vs 35%) than those 
retained in the study.  Participants lost to follow up were not different in terms of BMI, 
weight, psychological wellbeing, number of painful sites, or pain in specific sites 
(excepting neck pain).  Longitudinal analyses were inverse probability weighted for 
factors associated with loss to follow up. 
Study participants with higher BMI were at increased risk of prevalent or incident foot 
pain (Table 2, Table 5).  Figure 1 demonstrates that this association is linear cross-
sectionally, but is increased only in individuals with BMI ≥30 longitudinally.  
Compared to those with no painful joints, participants with 3 or more painful joints 
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were at increased risk of prevalent or incident foot pain, although the latter did not 
reach statistical significance (Table 2).   
We further investigated the effect of different methods of assessing fat mass on 
prevalent and incident foot pain, using standardised coefficients to enable 
comparability between different measures.  All simple methods of assessment, and 
metabolic syndrome were associated with foot pain cross-sectionally (Table 3), but 
of the more complex, DXA-based measures, fat mass was associated with foot pain 
cross–sectionally, even after adjustment for height.  Lean mass was associated with 
prevalent foot pain only when adjusted for height (Table 3). Incident foot pain was 
associated with all of the simple measures of fat mass longitudinally (weight, BMI, 
waist circumference, waist-to-hip ratio), with similar effect sizes longitudinally as 
observed in the cross–sectional analyses.  Of the DXA–based measures of fat and 
lean mass, lean mass (g) was statistically significant longitudinally (after adjustment 
for fat mass, age and sex, but not when adjusted for height).  No other DXA based 
fat mass measures were associated with incident foot pain.  When we examined the 
individual components of the metabolic syndrome (Table 4), only elevated waist 
circumference was statistically significant both cross-sectionally and longitudinally.   
Neither change in BMI nor change in weight predicted incident foot pain (Table 3).  
However, both weight and BMI were stable over 5 years in this population (Table 1).  
Study participants with poor psychological wellbeing were also at increased risk of 
foot pain at baseline; associations persisted over 5 years but did not reach statistical 
significance.  Steps per day was not associated with prevalent or incident foot pain 
over 5 years (Table 2, Table 5).  We also investigated associations between foot 
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pain and specific joints.  Associations were strongest at the neck, hands and knees; 
these were statistically significant both cross–sectionally and longitudinally (Table 2, 
Table 5).   
We conducted a sensitivity analysis on the Psychological Wellbeing score, as one of 
the items asked about pain, and therefore associations could be due to similarity in 
questions.  Omitting the question on pain and recalculating the scale with the 
remaining two items (sleep, how I generally feel) made minimal difference to 
associations (data not shown). 
Self-reported diabetes, and current or ever smoking were not associated with 
prevalent or incident foot pain after adjustment for age, sex and BMI (data not 
shown).    
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Discussion 
This prospective population-based study demonstrates that greater body mass and 
presence of joint pain at multiple sites are consistently associated with foot pain, 
both cross–sectionally and longitudinally, with every additional standard deviation of 
weight or BMI (approx. 15kg, or 4.75 unit increase in BMI) conferring a 20% increase 
in likelihood of prevalent foot pain and a 24% increase in risk of new foot pain over 5 
years.  Poor psychological wellbeing is also associated with foot pain cross-
sectionally, but did not remain statistically significant longitudinally even though 
effect sizes were similar.  Diabetes and smoking were not associated with either 
prevalent or incident foot pain.  Overall, reducing the burden of foot pain is in the 
community will require interventions aimed at multiple risk factors. 
The method of assessment of body mass did not affect the magnitude of positive 
associations between obesity and foot pain either cross–sectionally or longitudinally.  
These data are consistent with results of a recent meta–analysis, which found that 
BMI is associated with non–specific foot pain cross-sectionally [8]; and are 
consistent with data suggesting that the body composition measure with the 
strongest association with foot pain cross–sectionally is fat mass [11].  However, our 
data are not completely consistent with previous findings suggesting that BMI was 
associated with incident foot “problems” (as compared to pain); Menz et al reported 
that neither BMI nor weight at baseline was associated with incident foot pain in 
women aged 70 years and over, although having an increase in BMI >12% (RR 
1.14) was significantly associated with incident foot problems over a 6 year 
period [9].  We observed a 20% increased risk of baseline foot pain and a 24% 
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increase of incident foot pain per standard deviation in weight.  Differences in results 
between studies could be explained either by different populations or by different 
methods of comparison.  With regard to the more complex measures of assessing 
obesity, using DXA, fat mass was associated with foot pain cross–sectionally but not 
longitudinally (after adjustment for lean mass, age and sex, and normalised for 
height).  Lean mass was only associated with prevalent foot pain when normalised 
for height.  Associations between fat mass and foot pain could be due either to the 
effects of mechanical loading or via inflammatory factors, which are elevated in 
people with greater fat mass.  Our finding of an association with waist circumference 
supports a role for a metabolic effect, but it is unlikely to be driven by other 
components of metabolic syndrome (Table 4). Associations with lean mass and 
incident pain is novel and the reason behind this is unclear.  In contrast to Menz et 
al  [9], we did not find that change in weight or BMI were associated with incident 
foot pain after 5 years. However, the strength of this conclusion is tempered by the 
observation that these factors were stable over time in our population. 
We found that pain at other sites was associated with foot pain.  When expressed as 
number of affected sites, the threshold was three sites, but this was statistically 
significant only at baseline.  When the location of pain was taken into account, pain 
in the neck, hands or knees was associated with increased risk of prevalent and 
incident foot pain.  We found no such effect with pain in other regions assessed 
(shoulders, back, hips), but the reason for this remains unclear.  This is broadly 
consistent with existing literature [17, 18], although the specific sites associated with 
foot pain differed across studies. The association with knee pain could be explained 
biomechanically (i.e. knee pain may result in altered walking patterns which place 
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excessive loads on the foot), but the association with neck and hand pain requires 
an alternative explanation.  Possibilities include a form of generalised 
osteoarthritis [34], or other systemic factors eg inflammatory cytokines.  
Our data demonstrates associations between poor psychological wellbeing and 
existing foot pain, consistent with existing literature [9, 14, 18, 19].  Prevalence of 
foot pain was higher in this population than in other studies of comparable ages and 
populations [1].  This might be due to different definitions and time horizons.  We 
simply asked whether pain was present; the more widely used definitions 
(Framingham study, Manchester Foot Pain and Disability Index) require pain to be 
present on most days. Prevalence and incidence of foot pain was higher in males in 
this population, which is contrary to previous reports [1].  However, sex was not a 
correlate of foot pain at baseline or a predictor of new pain; therefore any differences 
in prevalence between sexes is unlikely to affect the applicability of study findings to 
the general population.   
Strengths of this study include the random population based sampling, 
comprehensive data collection, and five-year period of observation, providing 
excellent external validity for our findings. The initial response rate is similar to 
comparable Australian studies (57%)  [18].  Loss to follow up (~30%) was non–
random, as expected, but data have been adjusted for factors associated with follow 
up and the resulting observations are largely consistent with cross–sectional 
associations.   
Limitations include lack of clinical examination or imaging data on feet, which limits 
our ability to assess structural correlates and predictors of foot pain; and absence of 
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information on psychological factors, such as diagnosed mental health conditions or 
psychological distress: this limits our ability to consider such conditions as covariates 
or effect modifiers.  Also, our assessment of joint pain asks about a joint type 
(“knees”) but with the exception of the knees, collection of data on pain as binary 
(yes / no) precludes investigations of associations with pain severity or differentiation 
between 1 and 2 sore joints within these joint classes.  The latter is likely to increase 
measurement error, which would reduce strength of associations rather than 
increase it.   
Obesity is a modifiable risk factor, with evidence demonstrating that foot pain 
reduces following weight loss surgery [35], and weight loss results in a reduction in 
foot loading when walking [36]. However, change in BMI or weight were not 
associated with incident foot pain in our cohort, but weight was stable in this 
population (average change 0.43±4.5kg over 5 years) which may have limited our 
ability to detect a difference.  This data suggests a role for body mass as a driver of 
foot pain, with this association not being driven primarily by abdominal obesity. 
Conclusions 
Obesity and pain at other sites are consistently associated with prevalent foot pain 
and predict incident foot pain.  This suggests that reducing obesity in the community 
may reduce the prevalence of foot pain, and that taking a global approach to the 
treatment of pain may reduce both prevalence and incidence of foot pain in older 
adults. 
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Table 1: Characteristics of the study population at baseline, by presence of foot pain 
Baseline characteristics All study participants at baseline  
(Phase 1) (n=1092) 
Participants who completed 5 year follow up 
and did not have foot pain at baseline 
(n=494)  
No foot pain 
n=680 
Foot pain 
n=412 
p No new foot pain 
n=397 
New foot pain 
n=97 
p 
Age (years) 63.0 (7.4) 63.1 (7.6) 0.73 62.2 (7) 61.6 (7.2) 0.49 
Sex (% male) 51 45 0.037 54 41 0.02 
Current smokers (%) 12 11 0.65 11 7 0.32 
Diagnosed diabetes (%) (self-reported) 5.1 8.3 0.04 3.5 4.1 0.78 
Weight (kg) 76.5 (14.6) 80.2 (15.4) 0.0001 76.5 (13.9) 78.0 (15.8) 0.33 
Body mass index (BMI)  27.3 (4.4) 28.9 (5.2) <0.001 27.1 (4.1) 28.1 (4.8) 0.03 
Waist circumference (cm) 92.5 (12.7) 96.7 (13.5) <0.001 92.0 (12.3) 92.7 (12.6) 0.60 
Hip circumference (cm) 100.7 (8.4) 103.9 (9.3) <0.001 100.4 (8.1) 102.3 (8.7) 0.037 
Waist-hip ratio (waist/hip) 0.9 (0.1) 0.9 (0.1) 0.04 0.9 (0.1) 0.9 (0.1) 0.29 
Metabolic syndrome (%) 31 44 0.0001 30 32 0.78 
Total fat mass (kg) 27.0 (8.3) 30.5 (9.1) <0.001 26.5 (8.0) 28.0 (9) 0.056 
Total lean mass (kg) 52.1 (10.6) 52.1 (10.3) 0.90 52.6 (10.2) 52 (11.8) 0.58 
Leg strength (kg) 97.1 (48.5) 84.3 (48.9) <0.001 100.5 (48) 90.6 (50.5) 0.07 
Pedometer steps per day 9749 (3686) 8968 (3637) <0.001 9979 (3566) 10268 (4257) 0.81 
Proportion (%) with pain in the: 
   
   
  Neck 36 64 <0.001 31 48 0.50 
  Shoulder 36 58 <0.001 33 43 0.26 
  Back 53 76 <0.001 51 58 <0.001 
  Hands 32 64 <0.001 28 45 0.12 
  Hips 33 56 <0.001 31 39 <0.001 
  Knees 34 67 <0.001 30 44 <0.001 
Number of sites of pain 2.2 3.8 <0.001 2.0 2.8 <0.001 
Quality of life – Psychological Wellbeing  2 (1.5) 3 (1.6) <0.001 1.8 2.2 0.02 
mean ±standard deviation (SD).  P values calculated using t-tests. 
Body mass index (BMI)=(weight (kg) / height(m)2)
AUTHOR ACCEPTED MANUSCRIPT 
Page 21 
 
Table 2: Factors associated with foot pain at baseline and incident pain after 5 years:  
Number of painful joints 
 
Associations with foot pain at 
baseline 
Associations with incident 
foot pain after 5 years  
Prevalence ratio (95% CI) 
n=1042 
Risk ratio (95% CI) 
n=477† 
BMI 1.01 (1.01 to 1.02) 1.05 (1.01 to 1.09) 
Number of painful joints   
  0 Reference Reference 
  1-2 1.23 (0.82 to 1.86) 1.23 (0.66 to 2.30) 
  3-6 2.33 (1.6 to 3.4) 1.80 (0.98 to 3.30) 
Psychological Wellbeing 
subscale of the AQoL 1.16 (1.11 to 1.21) 1.07 (0.95 to 1.21) 
Steps per day§ 0.99 (0.96 to 1.01) 1.05 (0.99 to 1.12) 
Adjusted for age and sex, associations estimated using log-binomial regression 
§For each 1000 steps 
†Actual number of participants, analyses were inverse probability weighted for factors 
associated with loss to follow up 
 
 
Table 3: Associations between different measures of body fat and foot pain at 
baseline and incident pain after 5 years 
 
Associations with foot 
pain at baseline 
Associations with incident 
foot pain after 5 years  
RR per SD (95% CI) 
n=1092 
RR per SD (95% CI) 
n=476† 
Weight 1.20 (1.13 to 1.28) 1.24 (1.03 to 1.49) 
Body mass index (BMI) 1.19 (1.13 to 1.25) 1.24 (1.04 to 1.49) 
Waist circumference 1.26 (1.19 to 1.34) 1.22 (1.01 to 1.49) 
Hip circumference 1.19 (1.13 to 1.25) 1.18 (0.99 to 1.40) 
Waist-to-hip ratio 1.27 (1.16 to 1.39) 1.23 (0.95 to 1.61) 
Metabolic syndrome 1.21 (1.12 to 1.30) 1.25 (0.85 to 1.83) 
Total fat mass (kg)¥ 1.28 (1.18 to 1.40) 0.92 (0.71 to 1.19) 
Fat mass index  1.21 (1.18 to 1.24) 1.16 (0.93 to 1.46) 
Total lean mass (kg)§ 0.92 (0.78 to 1.08) 1.61 (1.07 to 2.43) 
Lean mass index 1.19 (1.05 to 1.34) 1.41 (1.11 to 1.79) 
Change in BMI - 1.11 (0.93 to 1.34) 
Change in weight  1.13 (0.93 to 1.36) 
Standardised coefficients used (RR per standard deviation) (excepting metabolic syndrome). 
All measures were at baseline except change in BMI and change in weight. 
Adjusted for age and sex, associations estimated using log binomial regression 
BMI: body mass index (weight / height2)  
Fat mass index: (fat mass / height2) 
Lean mass index:(lean mass / height2) 
¥Additionally adjusted for lean mass (kg)  
§Additionally adjusted for fat mass (kg)  
†Actual number of participants, analyses were inverse probability weighted for factors 
associated with loss to follow up 
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Table 4: Associations between components of metabolic syndrome and foot pain 
 
Associations with foot 
pain at baseline 
Prevalence ratio (95% CI)  
n=1079 
Associations with incident 
foot pain after 5 years 
Risk Ratio (95% CI) 
n=473† 
High waist circumference 1.49 (1.26 to 1.75) 1.58 (1.08 to 2.32) 
Low HDL 1.11 (0.9 to 1.36) 0.87 (0.5 to 1.52) 
High blood pressure 0.95 (0.8 to 1.13) 0.96 (0.64 to 1.44) 
High glucose 0.94 (0.79 to 1.12) 1.25 (0.82 to 1.89) 
High triglycerides 1.18 (1.00 to 1.39) 0.74 (0.46 to 1.18) 
All measures were at baseline.   
Adjusted for age and sex using log binomial regression 
†Actual number of participants, analyses were inverse probability weighted for factors 
associated with loss to follow up 
 
 
 
Table 5: Factors associated with foot pain at baseline and incident foot pain after 5 
years:  site of painful joint 
 
Associations with foot 
pain at baseline 
Associations with incident 
foot pain after 5 years  
Prevalence ratio (95% CI) 
n=1036 
Risk ratio (95% CI) 
n=477† 
BMI 1.01 (1.00 to 1.01) 1.05 (1.01 to 1.09) 
Painful joint  
 
  None Reference Reference 
  Neck 1.33 (1.1 to 1.61) 1.59 (1.03 to 2.44) 
  Shoulder 0.97 (0.84 to 1.13) 0.94 (0.61 to 1.45) 
  Back 1.17 (0.94 to 1.45) 0.81 (0.54 to 1.21) 
  Hand 1.52 (1.28 to 1.81) 1.58 (1.09 to 2.29) 
  Hips 1.06 (0.91 to 1.24) 0.84 (0.57 to 1.24) 
  Knees 1.67 (1.39 to 2.01) 1.47 (1.01 to 2.14) 
Psychological Wellbeing 
subscale of the AQoL 1.07 (1.04 to 1.09) 1.08 (0.96 to 1.21) 
Steps per day§ 0.99 (0.97 to 1.01) 1.06 (0.998 to 1.13) 
Adjusted for age and sex, estimates calculated using log binomial regression. 
§For each 1000 steps 
†Actual number of participants, analyses were inverse probability weighted for factors 
associated with loss to follow up 
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Figure 1: Prevalence of foot pain at baseline, and incident foot pain over 5 years, by 
categories of body mass index (unadjusted data) 
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